High throughput assay for novel pharmacological probes targeting cAMP signaling
针对 cAMP 信号传导的新型药理学探针的高通量测定
基本信息
- 批准号:8477859
- 负责人:
- 金额:$ 3.83万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-07-01 至 2013-06-30
- 项目状态:已结题
- 来源:
- 关键词:AgonistBindingBiochemicalBiological AssayBiological ProcessCellsCyclic AMPCyclic AMP ReceptorsCyclic AMP-Dependent Protein KinasesDiabetes MellitusDimensionsDiseaseEnvironmentEukaryotic CellFluorescenceGoalsGuanine Nucleotide Exchange FactorsGuanine NucleotidesHeart failureIntracellular Second MessengerLeadLibrariesLifeMalignant NeoplasmsMeasuresMediatingMedicalMolecularMolecular ProbesMonitorPhysiologicalPlayProteinsReactionRegulationResearchScreening procedureSecond Messenger SystemsSignal TransductionSpecificitySystemTestingTherapeuticTissuesassay developmentbasedesignhigh throughput screeninginnovationnovelphosphoric diester hydrolasepotency testingprogramspublic health relevanceresearch studysecond messengertool
项目摘要
DESCRIPTION (provided by applicant): cAMP-mediated cell signaling regulates a myriad of important biological processes under both physiological and pathological conditions, including diabetes, heart failure, and cancer. In eukaryotic cells, the effects of cAMP are transduced by two intracellular cAMP receptors, the classic protein kinase A/cAMP-dependent protein kinase (PKA/cAPK) and the recently discovered exchange protein directly activated by cAMP/cAMP-regulated guanine nucleotide exchange factor (Epac/cAMP-GEF). Like PKA, Epac contains a cAMP-binding domain, an evolutionally conserved structural motif that acts as a molecular switch for sensing intracellular second messenger cAMP levels. The discovery of Epac has opened a new dimension in studying the cAMP-mediated signaling as both PKA and Epac are ubiquitously expressed in all tissues. An increase in intracellular cAMP levels will lead to the activation of both PKA and Epac. Therefore, the net cellular effects of cAMP are not just dictated by PKA or Epac alone, but dependent upon the dynamic expression of Epac and PKA and their specific subcellular distribution in a particular tissue. Currently, the physiological functions of Epac are not clear. One of the major challenges within the research field is the lack of Epac-specific antagonists to dissect the specific physiological functions that Epac play in the overall cAMP-mediated signaling. The objective of this proposal is to develop a High Throughput Screening (HTS) assay for the discovery of novel molecular probes that are specific for Epac but not PKA. These Epac-specific probes will be powerful pharmacological tools for investigating the biological functions of Epac and molecular mechanism of cAMP signaling as well as, for promoting an understanding of disease mechanisms related to Epac/cAMP signaling.
PUBLIC HEALTH RELEVANCE: The goal of our proposed research is to develop a High Throughput Screening assay for the discovery of novel target-specific pharmacological probes that can be used for elucidating the mechanism of signal transduction mediated by an important second messenger, cAMP. The medical and pharmacological implications of this research program are far-reaching. Novel pharmacological probes targeting specific cAMP signaling components can potentially lead to the identification of mechanism-based therapeutic strategies for diseases associated with cAMP signaling.
描述(由申请人提供):cAMP 介导的细胞信号传导在生理和病理条件下调节无数重要的生物过程,包括糖尿病、心力衰竭和癌症。在真核细胞中,cAMP 的作用由两种细胞内 cAMP 受体转导,即经典蛋白激酶 A/cAMP 依赖性蛋白激酶 (PKA/cAPK) 和最近发现的由 cAMP/cAMP 调节的鸟嘌呤核苷酸交换因子直接激活的交换蛋白(Epac/cAMP-GEF)。与 PKA 一样,Epac 包含一个 cAMP 结合域,这是一种进化上保守的结构基序,可作为检测细胞内第二信使 cAMP 水平的分子开关。 Epac 的发现为研究 cAMP 介导的信号传导开辟了新的维度,因为 PKA 和 Epac 在所有组织中都普遍表达。细胞内 cAMP 水平的增加将导致 PKA 和 Epac 的激活。因此,cAMP 的净细胞效应不仅由 PKA 或 Epac 单独决定,还取决于 Epac 和 PKA 的动态表达及其在特定组织中的特定亚细胞分布。目前,Epac的生理功能尚不清楚。该研究领域的主要挑战之一是缺乏 Epac 特异性拮抗剂来剖析 Epac 在整个 cAMP 介导的信号传导中发挥的特定生理功能。该提案的目的是开发一种高通量筛选 (HTS) 检测方法,以发现针对 Epac 但不针对 PKA 的新型分子探针。这些 Epac 特异性探针将成为强大的药理学工具,用于研究 Epac 的生物学功能和 cAMP 信号传导的分子机制,以及促进对 Epac/cAMP 信号传导相关疾病机制的理解。
公共健康相关性:我们提出的研究的目标是开发一种高通量筛选方法,以发现新型靶标特异性药理学探针,这些探针可用于阐明重要的第二信使 cAMP 介导的信号转导机制。该研究项目的医学和药理学意义是深远的。针对特定 cAMP 信号传导成分的新型药理学探针可能有助于识别与 cAMP 信号传导相关的疾病的基于机制的治疗策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
XIAODONG CHENG其他文献
XIAODONG CHENG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('XIAODONG CHENG', 18)}}的其他基金
Significance of Epac signaling in renal Na+ handling and hypertension
Epac 信号在肾钠处理和高血压中的意义
- 批准号:
10864073 - 财政年份:2023
- 资助金额:
$ 3.83万 - 项目类别:
Epac1 as a novel therapeutic target for diabetic retinopathy
Epac1作为糖尿病视网膜病变的新型治疗靶点
- 批准号:
10689112 - 财政年份:2022
- 资助金额:
$ 3.83万 - 项目类别:
Exchange Protein directly Activated by cAMP (EPAC): Structure, Function and Therapeutics
cAMP 直接激活的交换蛋白 (EPAC):结构、功能和治疗
- 批准号:
10198941 - 财政年份:2017
- 资助金额:
$ 3.83万 - 项目类别:
Preclinical Development of Novel Rickettsiosis Therapeutics Targeting EPAC1
针对 EPAC1 的立克次体病新型疗法的临床前开发
- 批准号:
9038248 - 财政年份:2014
- 资助金额:
$ 3.83万 - 项目类别:
Preclinical Development of Novel Rickettsiosis Therapeutics Targeting EPAC1
针对 EPAC1 的立克次体病新型疗法的临床前开发
- 批准号:
8694342 - 财政年份:2014
- 资助金额:
$ 3.83万 - 项目类别:
Preclinical Development of Novel Rickettsiosis Therapeutics Targeting EPAC1
针对 EPAC1 的立克次体病新型疗法的临床前开发
- 批准号:
9250048 - 财政年份:2014
- 资助金额:
$ 3.83万 - 项目类别:
Novel Pharmacological Probes Targeting Exchange Proteins Activated by cAMP (EPAC)
针对 cAMP 激活的交换蛋白的新型药理学探针 (EPAC)
- 批准号:
8482964 - 财政年份:2013
- 资助金额:
$ 3.83万 - 项目类别:
High throughput assay for novel pharmacological probes targeting cAMP signaling
针对 cAMP 信号传导的新型药理学探针的高通量测定
- 批准号:
7991500 - 财政年份:2010
- 资助金额:
$ 3.83万 - 项目类别:
Genetic Screening:Oncogene RAS-Based Inhibi*(RMI)
基因筛查:Oncogene RAS-Based Inhibi*(RMI)
- 批准号:
7058055 - 财政年份:2005
- 资助金额:
$ 3.83万 - 项目类别:
Epac/cAMP-GEF, A Novel Intracellular cAMP Receptor
Epac/cAMP-GEF,一种新型细胞内 cAMP 受体
- 批准号:
8762253 - 财政年份:2003
- 资助金额:
$ 3.83万 - 项目类别:
相似国自然基金
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:
利用分子装订二硫键新策略优化改造α-芋螺毒素的研究
- 批准号:82104024
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
CST蛋白复合体在端粒复制中对端粒酶移除与C链填补调控的分子机制研究
- 批准号:31900521
- 批准年份:2019
- 资助金额:26.0 万元
- 项目类别:青年科学基金项目
Wdr47蛋白在神经元极化中的功能及作用机理的研究
- 批准号:31900503
- 批准年份:2019
- 资助金额:26.0 万元
- 项目类别:青年科学基金项目
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
- 批准号:31672538
- 批准年份:2016
- 资助金额:62.0 万元
- 项目类别:面上项目
相似海外基金
Small Molecule Degraders of Tryptophan 2,3-Dioxygenase Enzyme (TDO) as Novel Treatments for Neurodegenerative Disease
色氨酸 2,3-双加氧酶 (TDO) 的小分子降解剂作为神经退行性疾病的新疗法
- 批准号:
10752555 - 财政年份:2024
- 资助金额:
$ 3.83万 - 项目类别:
Estrogen, Astrocyte Reactivity, and Sex Differences in Alzheimer's Disease
阿尔茨海默病中的雌激素、星形胶质细胞反应性和性别差异
- 批准号:
10662993 - 财政年份:2023
- 资助金额:
$ 3.83万 - 项目类别:
The Role of Sensory Receptors in Angelman Syndrome
感觉感受器在天使综合症中的作用
- 批准号:
10630683 - 财政年份:2023
- 资助金额:
$ 3.83万 - 项目类别:
Probing Mechanisms of Polycystin-1 Regulation Using Peptide Modulators Designed by Sequence- and Structure-Based Learning
使用基于序列和结构的学习设计的肽调制器探索多囊蛋白-1 调节机制
- 批准号:
10917464 - 财政年份:2023
- 资助金额:
$ 3.83万 - 项目类别: